In Brief
Ettinger et al. report that the neuronal migration protein doublecortin (DCX) is an ''anti-+TIP'' in cells that is excluded from growing microtubule (MT) ends. DCX preferentially binds to straight MTs in the absence but to curved MT segments in the presence of taxanes, supporting a model in which DCX recognizes the compacted GDP-like MT lattice.
SUMMARY
Many microtubule (MT) functions are mediated by a diverse class of proteins (+TIPs) at growing MT plus ends that control intracellular MT interactions and dynamics and depend on end-binding proteins (EBs) [1] . Cryoelectron microscopy has recently identified the EB binding site as the interface of four tubulin dimers that undergoes a conformational change in response to b-tubulin GTP hydrolysis [2, 3] . Doublecortin (DCX), a MT-associated protein (MAP) required for neuronal migration during cortical development [4, 5] , binds to the same site as EBs [6] , and recent in vitro studies proposed DCX localization to growing MT ends independent of EBs [7] . Because this conflicts with observations in neurons [8, 9] and the molecular function of DCX is not well understood, we revisited intracellular DCX dynamics at low expression levels. Here, we report that DCX is not a +TIP in cells but, on the contrary, is excluded from the EB1 domain. In addition, we find that DCX-MT interactions are highly sensitive to MT geometry. In cells, DCX binding was greatly reduced at MT segments with high local curvature. Remarkably, this geometry-dependent binding to MTs was completely reversed in the presence of taxanes, which reconciles incompatible observations in cells [9] and in vitro [10] . We propose a model explaining DCX specificity for different MT geometries based on structural changes induced by GTP hydrolysis that decreases the spacing between adjacent tubulin dimers [11] . Our data are consistent with a unique mode of MT interaction in which DCX specifically recognizes this compacted GDP-like MT lattice.
RESULTS AND DISCUSSION
Although doublecortin (DCX) has been proposed to bind, stabilize, and nucleate microtubules (MTs) [12] , early studies on DCX-MT interactions in cells suffered from potential overexpression phenotypes such as massive MT bundling [5] . In contrast, recent studies proposed end-binding protein (EB)-independent DCX plus-end tracking at very low concentrations in vitro [7] . Because this is consistent with DCX recognizing the same site between tubulin dimers and between protofilaments that determines EB plus-end tracking [2, 6] , we reexamined intracellular DCX dynamics at low expression levels that are likely similar to endogenous expression in developing neurons. In several stably expressing human cell lines generated by lentivirus transduction, which include non-transformed HaCaT keratinocytes as well as MDA-MB-231 or H1299 cancer cells, DCX-EGFP appeared evenly distributed along individual MTs, and bound MTs with high affinity indicated by the very low level of DCX-EGFP in the cytoplasm ( Figure 1A ; Movie S1). MT binding required both DCX domains and constructs containing only the N-or C-terminal DCX domains showed no MT association in cells ( Figure 1F ) [13] . At these expression levels, we did not observe noticeable MT bundling and MTs remained dynamic although DCX-EGFP decreased MT shortening rates by 30% ( Figure 1B) . Nevertheless, DCX-EGFP did not obviously interfere with interphase or mitotic remodeling of the MT cytoskeleton and did not inhibit cell migration ( Figure 1D ; Movie S2). At very low expression levels, DCX-EGFP labeling along MTs appeared speckled and the speckle pattern fluctuated rapidly indicating highly dynamic binding kinetics ( Figure 1C ; Movie S3). Even at these expression levels, DCX-EGFP was never enriched near MT plus ends regardless of whether these MTs were growing or shortening ( Figure 1C ) demonstrating that, even at the lowest observable intracellular concentration, DCX does not display MT plus-endtracking behavior in cells. Because non-neuronal cells do not normally express DCX, we confirmed these observations in rat embryonic primary neurons infected with the DCX-EGFP lentivirus and found similar DCX-EGFP localization along MTs and no enrichment at growing MT ends ( Figure 1E ).
Because DCX recognizes the same site on MTs as EB1 [2, 6] , we next asked whether DCX and EB1 compete for binding sites near growing MT ends. To this end, we observed the MT-binding domain of EB1 tagged with mCherry (EB1DC-mCherry) [14] in DCX-EGFP-expressing cells. In images in which both fluorescence channels were acquired simultaneously to eliminate spatial shift between channels due to MT growth or movement, DCX-EGFP appeared to be excluded from the EB1DC-mCherry domain near growing MT ends (Figure 2A ; Movie S4). To quantitatively compare DCX and EB1 binding, we then fitted fluorescence intensity profiles of fast-growing MTs underneath the nucleus where MTs are relatively sparse and can be traced unambiguously with Gaussian-convolved models of exponentially decaying (EB1) or stepwise (DCX) MT binding [15, 16] (Figure 2C) . Calculation of the distance between the start of the underlying exponential decay, x peak , and the step of the step function, x step , from these curve fits revealed that DCX binding lags behind EB1 by 530 ± 280 nm (mean ± SD) ( Figure 2D ). In contrast, in control experiments comparing TUB-EGFP and EB1DC-mCherry intensity profiles there was no measurable difference between the EB1 maximum and the MT end (80 ± 220 nm; Figures 2B and 2D ). In addition, the half maximum of DCX-EGFP binding increase, i.e., x step , coincided with the half maximum of EB1 decay ( Figure 2E ), indicating that EB1 and DCX binding are indeed mutually exclusive. To exclude that elevated EB1DC-mCherry expression competed with DCX binding, we stained for EB1 in DCX-EGFP-expressing cells and consistent with our live-cell experiments DCX-EGFP did not overlap with endogenous EB1 MT plus end comets in HaCaT ( Figures 2G and 2H ) and other cell types ( Figure S2 ).
In addition, in vitro, DCX-EGFP plus-end tracking is only observed at very low concentrations (<5 nM) [10] , which is 5-fold below the K D reported for EB1 at MT plus ends [16] . Thus, if DCX competed with EB1 for the same binding site, DCX should bind with higher affinity and displace EB1 from MT plus ends. However, this was not the case, and the half-maximum width determined from the exponentially modified Gaussian fits of EB1DC-mCherry (Figure 2F ) or endogenous EB1 comets (Figure 2I ) remained unchanged in the presence of DCX-EGFP. Conversely, DCX binding along MTs was not reduced in cells expressing high levels of EB1DC-mCherry at which EB1 begins to bind along MTs ( Figures 2J and 2K) . Finally, the zone of DCX-EGFP exclusion from growing MT ends correlated with EB1 comet length ( Figure 2H ), indicating that faster growing MTs have a longer zone without DCX at the plus end. Together, these data strongly indicate that in cells DCX and EB1 do not compete for binding but instead may recognize the same interface between four tubulin dimers in different conformational states. These different MT conformations are most likely defined by different GTP hydrolysis states suggesting that DCX specifically recognizes the GDP-MT lattice. This is indeed consistent with in vitro findings that, in contrast to EB1, DCX shows no increased affinity for MTs assembled in the presence of nucleotide analogs that are believed to mimic either the GTP-or the GDP-Pi-bound MT conformation [10] .
Although at first glance DCX-EGFP appeared to decorate all intracellular MTs evenly, upon closer inspection we noticed that DCX-EGFP fluorescence was strongly reduced on curved MTs ( Figure 3A ; see also Movie S1). This loss of DCX-EGFP from curved MTs was highly dynamic and reversible: DCX-EGFP dis-and reappearance correlated tightly with MT buckling and straightening, both in time and space ( Figure 3B ). To quantify this dependence of DCX-MT binding on MT geometry, we analyzed DCX-EGFP fluorescence intensity as a function of local MT curvature of a large number of MT segments and determined that DCX-EGFP dissociated from MTs with increasing local curvature ( Figure 3C ). Conversely, as expected, TUB-EGFP fluorescence intensity did not depend on MT curvature ( Figure 3D ). This preference of DCX for straight MTs was surprising as the opposite was recently reported, namely, that DCX specifically recognizes highly curved MTs in vitro [10] even though earlier reports also noted decreased DCX staining at bent MTs in neuronal growth cones [9] . Of note, although the vast majority of straight MTs was DCX-decorated, we observed rare occurrences in which few straight MTs did not bind DCX, which may suggest lattice defects resulting in unusual protofilament number [7, 12] .
To reconcile these conflicting results, we considered possible mechanisms by which DCX might recognize MT curvature.
Because the loss of DCX-EGFP along curved MT segments was spatially and temporally uniform, it is likely not due to MT lattice defects that would occur in a more anisotropic manner [17] . At a curvature of 1 mm -1 , at which DCX-EGFP binding reaches a lower plateau, the angle between adjacent tubulin dimers along a protofilament is less than 0.5 , and it is difficult to imagine how such a small deviation from straightness could be recognized. However, assuming tubulin subunits do not normally exchange from within the MT lattice, the number of tubulin dimers per unit length of MT has to be the same along the inside and outside protofilament of a curved MT. At a curve radius of 1 mm and the known MT thickness of 25 nm, tubulin dimer spacing on the outside of the curved MT thus has to be 2.5% larger compared with the inside (Figure S2 ). Strikingly, this is extremely close to the recently reported structural difference between the GTP-tubulin lattice with a subunit spacing of 8.3 nm and the compacted GDP-tubulin lattice with a subunit spacing of 8.1 nm [11] . This structural change predominantly occurs at the interface between tubulin dimers along a protofilament, which constitutes the DCX binding pocket [6] . It is thus conceivable that DCX is sensitive to this conformational change between adjacent tubulin dimers. Assuming that the 8.1-nm tubulin dimer spacing cannot be compressed any further, the protofilament along the outside of a curved GDP-MT would have to adopt a GTP-like conformation. Therefore, along a curved MT DCX would be expected to remain bound to the inside curvature but dissociate from the outside consistent with the significant reduction in binding but not total loss of DCX signal that we see in our data ( Figure 3H ).
Paclitaxel binding to MTs stabilizes the GTP lattice conformation and reverses lattice compaction following GTP hydrolysis [11, 18] . Thus, we predicted that paclitaxel prevents DCX binding to MTs. Indeed, the effect of paclitaxel addition was rapid and dramatic. Within minutes, concurrent with paclitaxel diffusion into the cell, DCX-EGFP rapidly dissociated from straight MTs ( Figure 3F ; Movie S5). Depending on paclitaxel concentration, DCX-EGFP appeared to localize to growing MT plus ends for a short period of time, which we interpret as lag between MT polymerization and paclitaxel binding ( Figure 3F ; Movie S5). After a , the outside spacing between tubulin dimers must be 2.5% larger compared with the inside resulting in an expansion of tubulin dimer spacing. The observed DCX-EGFP distribution along MTs in control and paclitaxel-treated cells is thus consistent with DCX recognition of the GDP-like MT lattice conformation. For simplicity, individual protofilaments are not drawn. See also Figure S2. few minutes, DCX-EGFP remained bound only to MT segments with high local curvature (Figures 3E-3G ). Similar to the logic outlined above, compression of the inside of curved taxane-bound MTs in a GTP-like conformation to GDP-like spacing would restore DCX binding to the inside protofilaments of a curved MT ( Figure 3H ), which now also fits with the in vitro data in which DCX binding was tested on paclitaxel-stabilized MTs [10] . Taken together, these data are consistent with the hypothesis that DCX specifically recognizes the compacted tubulin dimer spacing characteristic of the GDP-MT lattice. Because DCX is excluded from the EB1-binding domain near growing MT ends (Figure 2 ), our data also indirectly suggest that MT lattice compaction occurs after E-site phosphate release as it is thought that EB1 recognizes the GDP-Pi tubulin state following GTP hydrolysis [2, 3, 16] .
Because this represents a previously unappreciated mode of recognition of MT conformation, we tested the only other MTassociated protein, the neuronal MAPT (tau), for which a similar sensitivity to MT geometry has previously been reported [19] . In contrast to DCX, mCherry-MAPT was enriched at curved MT segments in both control and paclitaxel-treated cells, and paclitaxel decreased MAPT-MT binding along both straight and curved MT segments (Figure 4 ). This indicates that MAPT recognizes curved MTs through a mechanism that is distinct from DCX and cannot directly rely on inter-tubulin dimer spacing. MAPT and MAP4 belong to a family of structurally related proteins that bind MTs through a repeat array of electrostatic interactions [20] . However, unlike neuronal MAPT, the more ubiquitously expressed MAP4 was completely insensitive to both MT curvature and paclitaxel ( Figure 4) . Thus, recognition of MT curvature is not an intrinsic property of the classic KXGS MT-binding motif.
In conclusion, we propose that DCX is the first example of an ''anti-+TIP'' that specifically recognizes the GDP-MT lattice conformation. Our results are consistent with a recent analysis of MT ultrastructure in the absence and presence of paclitaxel [11] , and the simplest explanation for the observed discrimination between straight and curved MT segments is compression or expansion of the DCX binding pocket between adjacent tubulin dimers at a local MT curvature that is typically observed in cells as a result of compressive forces [21] . Similarly, compression of the GTP-like MT lattice at outwardly curved protofilaments in vitro [22] could result in high-affinity DCX binding sites anterior to the GDP-Pi EB1 binding platform, explaining DCX plus-end tracking at very low concentrations in vitro and observed differences between EB1 and DCX dynamics [10] . In vitro, DCX also discriminates between 13 and 14 protofilament MTs [7] indicating that lateral curvature or interactions between adjacent protofilaments can contribute to DCX binding. However, because lateral contacts between protofilaments only minimally differ in different nucleotide conditions [11] , we believe it is unlikely that these play a role in the observed DCX binding response to longitudinal curvature or paclitaxel binding. Currently, we cannot explain why DCX plus-end tracking does not occur in cells. Because our live-cell imaging is sufficiently sensitive to observe DCX-EGFP speckles along MTs at low expression levels that likely reflect binding dynamics of few molecules, it seems unlikely that we lack the sensitivity to detect DCX-EGFP on MT tips if it were there. MT polymerization dynamics in cells and in vitro are fundamentally different and it is possible that high-affinity DCX binding sites at the outermost tips of growing MTs do not exist or are inaccessible in cells. Alternatively, differences in MT protofilament numbers (13 in cells versus predominantly 14 in MTs nucleated in vitro from seeds assembled with non-hydrolyzable GTP analogs [23] ) and thus lattice geometry or different posttranslational modifications may explain the observed differences between cells and in vitro. Although we can only speculate what the biological function of this recognition of a specific MT geometry may be, it is possible that DCX binding stabilizes the compacted GDPlattice conformation and thus stiffens MTs consistent with qualitative observations that DCX increases the number of straight MTs in neuronal cells [9] . To our knowledge, the sensitivity of DCX interaction with MTs to taxane-induced changes in MT structure is unique and demonstrates that in vitro MT-binding assays that are predominantly carried out in the presence of paclitaxel have to be interpreted carefully. Finally, DCX and MAPT are both neuronal MAPs. Taxane neuropathy is a widely acknowledged but poorly understood potentially severe side effect of chemotherapy [24] , and it will be interesting to evaluate to what extent taxane-induced alterations in DCX and MAPT MT interactions contribute to taxane neurotoxicity.
EXPERIMENTAL PROCEDURES
Human DCX (GenBank: NM_178152) [25] was C-terminally tagged with EGFP and cloned into a lentivirus expression vector. HaCaT cells were cultured, and stable lines were generated by lentivirus transduction and imaged by spinningdisk confocal microscopy essentially as previously described [26] [27] [28] . Detailed experimental and image analysis procedures are included in the Supplemental Experimental Procedures. 
